Our study reveals that lactylation-induced NSUN2-mediated RNA m5C modification is a crucial driver of PNI in PDAC, highlighting NSUN2 inhibition as a novel and promising therapeutic strategy for addressing this aggressive feature of pancreatic cancer. Here, NSUN2 is linked to familial pancreatic carcinoma.